Systematic ReviewSystematic Review
Open Access

Hypothyroidism is a risk factor for transient ischemic attack

A meta-analysis

Jian Li, Hui Liu and Yan Li
Saudi Medical Journal February 2025, 46 (2) 117-123; DOI: https://doi.org/10.15537/smj.2025.46.2.20240508

References

  1. 1.↵
    1. Murolo M,
    2. Di Vincenzo O,
    3. Cicatiello AG,
    4. Scalfi L,
    5. Dentice M
    . Cardiovascular and neuronal consequences of thyroid hormones alterations in the ischemic stroke. Metabolites 2022; 13: 22.
    OpenUrlPubMed
  2. 2.↵
    1. Feigin VL,
    2. Stark BA,
    3. Johnson CO,
    4. Roth GA,
    5. Bisignano C,
    6. Abady GG, et al.
    Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20: 795-820.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Li XY,
    2. Kong XM,
    3. Yang CH,
    4. Cheng ZF,
    5. Lv JJ,
    6. Guo H, et al.
    Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021. EClinicalMedicine 2024; 75: 102758.
    OpenUrlPubMed
  4. 4.↵
    1. Long B,
    2. Marcolini E,
    3. Gottlieb M
    . Emergency medicine updates: transient ischemic attack. Am J Emerg Med 2024; 83: 82-90.
    OpenUrlPubMed
  5. 5.↵
    1. Kleindorfer DO,
    2. Towfighi A,
    3. Chaturvedi S,
    4. Cockroft KM,
    5. Gutierrez J,
    6. Lombardi-Hill D, et al.
    2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52: e364-e467.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Chinese Medical Association Neurology Branch, Cerebrovascular Disease Group of Chinese Medical Associate Neurology Branch. Chinese guideline for the secondary prevention of ischemic stroke and transient ischemic attack 2022. Chin J Neurol 2022; 55: 40.
    OpenUrl
  7. 7.↵
    1. Chaker L,
    2. Razvi S,
    3. Bensenor IM,
    4. Azizi F,
    5. Pearce EN,
    6. Peeters RP
    . Hypothyroidism. Nat Rev Dis Primers 2022; 8: 30.
    OpenUrlPubMed
  8. 8.↵
    1. Akhoundi FH,
    2. Ghorbani A,
    3. Soltani A,
    4. Meysamie A
    . Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidism. Neurology 2011; 77: 349-354.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Wollenweber FA,
    2. Zietemann V,
    3. Gschwendtner A,
    4. Opherk C,
    5. Dichgans M
    . Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke 2013; 44: 1446-1448.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Wells GA,
    2. Shea B,
    3. O’Connell D,
    4. Peterson J,
    5. Welch V,
    6. Losos M
    . The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. [Updated 2000; accessed 2019 Apr]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  11. 11.↵
    1. Zeng X,
    2. Zhang Y,
    3. Kwong JS,
    4. Zhang C,
    5. Li S,
    6. Sun F, et al.
    The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015; 8: 2-10.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Benvenga S,
    2. Pantano R,
    3. Saraceno G,
    4. Lipari L,
    5. Alibrando A,
    6. Inferrera S, et al.
    A minimum of 2 years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of l-thyroxine, may have metabolic and cardiovascular consequences. J Clin Transl Endocrinol 2019; 16: 100189.
    OpenUrlPubMed
  13. 13.
    1. Dörr M,
    2. Empen K,
    3. Robinson DM,
    4. Wallaschofski H,
    5. Felix SB,
    6. Völzke H
    . The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. Eur J Endocrinol 2008; 159: 145-152.
    OpenUrlAbstract/FREE Full Text
  14. 14.
    1. Drechsler C,
    2. Schneider A,
    3. Gutjahr-Lengsfeld L,
    4. Kroiss M,
    5. Carrero JJ,
    6. Krane V, et al.
    Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis 2014; 63: 988-996.
    OpenUrlCrossRefPubMed
  15. 15.
    1. Karakurum Goksel B,
    2. Karatas M,
    3. Nebioglu A,
    4. Sezgin N,
    5. Tan M,
    6. Seydaoglu G, et al.
    Subclinical hypothyroidism, hyperhomocysteinemia and dyslipidemia: investigating links with ischemic stroke in Turkish patients. Neurol Res 2007; 29: 871-876.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Karch A,
    2. Thomas SL
    . Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study. Neurology 2014; 82: 1643-1652.
    OpenUrlPubMed
  17. 17.
    1. Rodondi N,
    2. Newman AB,
    3. Vittinghoff E,
    4. de Rekeneire N,
    5. Satterfield S,
    6. Harris TB, et al.
    Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005; 165: 2460-2466.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Schultz M,
    2. Kistorp C,
    3. Raymond I,
    4. Dimsits J,
    5. Tuxen C,
    6. Hildebrandt P, et al.
    Cardiovascular events in thyroid disease: a population based, prospective study. Horm Metab Res 2011; 43: 653-659.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Yin X,
    2. Wang D
    . Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med 2018; 379: 1579-1580.
    OpenUrlPubMed
  20. 20.
    1. Turner GM,
    2. Calvert M,
    3. Feltham MG,
    4. Ryan R,
    5. Finnikin S,
    6. Marshall T
    . Clinical and demographic characteristics associated with suboptimal primary stroke and transient ischemic attack prevention: retrospective analysis. Stroke 2018; 49: 682-687.
    OpenUrlAbstract/FREE Full Text
  21. 21.
    1. Sato S,
    2. Anderson CS
    . Central nervous system disorders: transient ischemic attack and stroke (ischemic/hemorrhagic). Disorders of blood pressure regulation: phenotypes, mechanisms, therapeutic options. [Updated 2017; accessed date? [D/M/Y]. Available from: https://link.springer.com/chapter/10.1007/978-3-319-59918-2_20
  22. 22.↵
    1. Tan YF,
    2. Zhan LX,
    3. Chen XH,
    4. Guo JJ,
    5. Qin C,
    6. Xu E
    . Risk factors, clinical features and prognosis for subtypes of ischemic stroke in a Chinese population. Curr Med Sci 2018; 38: 296-303.
    OpenUrlPubMed
  23. 23.↵
    1. Amarenco P
    . Transient ischemic attack. N Engl J Med 2020; 382: 1933-1941.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Venketasubramanian N
    . Ischemic stroke: new insights from risk factors, mechanisms and outcomes. J Cardiovasc Dev Dis 2023; 10: 472.
    OpenUrlPubMed
  25. 25.↵
    1. Remmel KS,
    2. Wanahita A,
    3. Moore K,
    4. Gruenthal M
    . Acute ischemic stroke and hypothyroidism. J Ky Med Assoc 2006; 104: 191-193.
    OpenUrlPubMed
  26. 26.↵
    1. Squizzato A,
    2. Gerdes VE,
    3. Brandjes DP,
    4. Büller HR,
    5. Stam J
    . Thyroid diseases and cerebrovascular disease. Stroke 2005; 36: 2302-2310.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Öztürk Ü,
    2. Vural P,
    3. Özderya A,
    4. Karadağ B,
    5. Doğru-Abbasoğlu S,
    6. Uysal M
    . Oxidative stress parameters in serum and low density lipoproteins of Hashimoto’s thyroiditis patients with subclinical and overt hypothyroidism. Int Immunopharmacol 2012; 14: 349-352.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords